Skip to main content
SpringerLink
Log in

Pneumologie

Welche Asthmapatienten profitieren von Biologika?

The position of biologics in the asthma management

  • FB_Übersicht
  • Published:
MMW - Fortschritte der Medizin Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Mod. nach www.ginasthma.com, Abruf 25.6.2020

Author information

Authors and Affiliations

  1. Abt. Innere Medizin\/Pneumologie\/Klinik am Steinenberg, Stuttgarter Str. 100, 72574, Reutlingen\/Bad Urach, Deutschland

    Adrian Gillissen

Authors
  1. Adrian Gillissen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adrian Gillissen.

Ethics declarations

Honorierte Vorträge: AstraZeneca, Berlin-Chemie, Novartis, Chiesi; Advisory Boards: AstraZeneca, Boehringer Ingelheim, Berlin-Chemie, Chiesi; Reisekostenübernahmen: AstraZeneca, Berlin-Chemie; Forschungsgelder (auch via Institution): Keine; Aktien: keine

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gillissen, A. Welche Asthmapatienten profitieren von Biologika?. MMW - Fortschritte der Medizin 163, 55–59 (2021). https://doi.org/10.1007/s15006-021-9630-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-021-9630-3

Keywords:

Search

Navigation